U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT06882681) titled 'Silymarin Bioavailability Study' on March 12.
Brief Summary: This study seeks to evaluate and compare the pharmacokinetics of a novel micellar silymarin formulation with that of a standard silymarin formulation.
Study Start Date: May 01, 2024
Study Type: INTERVENTIONAL
Condition:
Bioavailability and Pharmacokinetics
Intervention:
DIETARY_SUPPLEMENT: LipoMicel Milk Thistle
A maximum single dose of approx. 140 mg silymarin (in soft gel capsule)
DIETARY_SUPPLEMENT: Unformulated Milk Thistle Extract
A maximum single dose of approx. 130 mg silymarin (in hard gel capsules)
Recruitment Status: COMPLETED
Sponsor: Isura
Publishe...